PAR
Click for more information
5.00% 19.0¢ paradigm biopharmaceuticals limited..

imo $6.3m is quite a disappointing R&D rebate estimate.

  1. boslo
    729 Posts.
    lightbulb Created with Sketch. 138
    clock Created with Sketch.
    31/07/23
    12:23
    Post #: 69077865
    imo $6.3m is quite a disappointing R&D rebate estimate.
    PAR Price at posting: 94.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
RDN Preliminary interpretation of Andover South reveals key NE-trending corridor hosting lithium mineralization
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.0¢ 		Change
-0.010(5.00%) 		Mkt cap ! $66.54M
Open High Low Value Volume
20.0¢ 21.0¢ 19.0¢ $203.4K 1.019M

Buyers (Bids)

No. Vol. Price($)
14 387930 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 65468 2
View Market Depth
Last trade - 16.10pm 27/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.